In spite of the progress made in vaccine and antiviral therapy development, hepatitis B virus (HBV) infection remains a major health care problem. Over 350 million people are chronically infected worldwide, showing differences in the severity of liver disease, clinical outcome and response to immune and antiviral-therapy.
In spite of the progress made in vaccine and antiviral therapy development, hepatitis B virus (HBV) infection remains a major health care problem. Ove...
